Camila Anton
Overview
Explore the profile of Camila Anton including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
25
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lemos C, Anton C, Machado F, Bernardi R, Freitas A, Silva D
Rev Assoc Med Bras (1992)
. 2022 Oct;
68(9):1199-1203.
PMID: 36228251
Objectives: In tuberculosis treatment, corticosteroids are used as adjuvants, especially in meningeal/pericardial tuberculosis. In other forms of the disease, especially in severe tuberculosis requiring mechanical ventilation, its use is controversial....
2.
Bernardi R, Holler S, Almeida E, Anton C, Machado F, Silva D
Rev Iberoam Micol
. 2022 Apr;
39(2):31-35.
PMID: 35461766
Background: Several studies to evaluate the accuracy of galactomannan (GM) in bronchoalveolar lavage fluid (BALF) as a diagnostic tool have been carried out; however, there are still controversies about the...
3.
Machado F, Gehlen M, Caron V, Mousquer G, Bello G, Anton C, et al.
Infection
. 2021 Jan;
49(3):457-461.
PMID: 33385298
Purpose: The establishment of candidate genetic determinants associated with tuberculosis (TB) is a challenge, considering the divergent frequencies among populations. The objective of this study was to evaluate the association...
4.
Anton C, Lemos C, Machado F, Bernardi R, Freitas A, Silva D
Trop Med Int Health
. 2020 Nov;
26(1):111-114.
PMID: 33159399
Objectives: Adequate anti-tuberculosis (TB) treatment is an important factor that can affect the patient's outcome. Higher mortality is found in patients who do not receive optimal treatment that includes isoniazid...
5.
Azeredo A, Holler S, Almeida E, Cionek O, Loureiro M, Freitas A, et al.
Workplace Health Saf
. 2020 Jun;
68(11):519-525.
PMID: 32502371
: Most studies that have evaluated the impact of infection-control measures (ICM) reported a decrease in latent tuberculosis (TB) and not in TB. The objective of this study was to...
6.
Anton C, Machado F, Ramirez J, Bernardi R, Esther Palominos P, Brenol C, et al.
J Bras Pneumol
. 2019 May;
45(2):e20190023.
PMID: 31038654
Most people infected by Mycobacterium tuberculosis (Mtb) do not have any signs or disease symptoms, a condition known as latent tuberculosis infection (LTBI). The introduction of biological agents, mainly tumor...